Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/M cell cycle arrest

Experimental Dermatology

Volumn 17, Issue 4, 2008, Pages 312-317

  Kim, Dong Seok ^a   Lee, Hyun Kyung ^b   Park, Seo Hyoung ^b   Lee, Sangku ^c   Ryoo, In Ja ^c   Kim, Won Gon ^c   Yoo, Ick Dong ^c   Na, Jung Im ^b   Kwon, Sun Bang ^d   Park, Kyoung Chan ^b  

^a Chung Ang University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Welskin Co Ltd   (South Korea)

Author keywords

Cell cycle; ERK; Keratinocytes; Proliferation; Terrein

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TERREIN;

ADOLESCENT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DOWN REGULATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

BUTADIENES; CDC2 PROTEIN KINASE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLOPENTANES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; KERATINOCYTES; NITRILES; PHOSPHORYLATION; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION;

EID: 40349102097     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00646.x     Document Type: Article

References (24)

1. Park S H, Kim D S, Kim W G et.al. Terrein: A new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 2004: 61: 2878-2885.
2. Harper J K, Mulgrew A E, Li J Y, Barich D H, Strobel G A, Grant D M. Characterization of stereochemistry and molecular conformation using solid-state NMR tensors. J Am Chem Soc 2001: 123: 9837-9842.
3. Kim D S, Cho H J, Lee H K et.al. Terrein, a fungal metabolite, inhibits the epidermal proliferation of skin equivalents. J Dermatol Sci 2007: 46: 65-68.
4. DiSepio D, Chandraratna R A. New drugs in the treatment of psoriasis. Expert Opin Investig Drugs 2000: 9: 79-93.
5. Blenis J. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 1993: 90: 5889-5892.
6. Blumer K J, Johnson G L. Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 1994: 19: 236-240.
7. Sale E M, Atkinson P G, Sale G J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 1995: 14: 674-684.
8. Marshall C J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995: 80: 179-185.
9. Dufourny B, Alblas J, van Teeffelen H A et.al. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 1997: 272: 31163-31171.
10. Kim D S, Kim S Y, Moon S J et.al. Ceramide inhibits cell proliferation through Akt/PKB inactivation and decreases melanin synthesis in Mel-Ab cells. Pigment Cell Res 2001: 14: 110-115.
11. Kim D S, Kim S Y, Kleuser B, Schafer-Korting M, Kim K H, Park K C. Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal 2004: 16: 89-95.
12. Morgan D O. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997: 13: 261-291.
13. Tang P P, Hsieh S C, Wang F F. Modulation of caspase activation and p27(Kip1) degradation in the p53-induced apoptosis in IW32 erythroleukemia cells. Cell Signal 2002: 14: 961-968.
14. Lee S, Kim W G, Kim E et.al. Synthesis and melanin biosynthesis inhibitory activity of (+/-)-terrein produced by Penicillium sp. 20135. Bioorg Med Chem Lett 2005: 15: 471-473.
15. Dooley T P, Gadwood R C, Kilgore K, Thomasco L M. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol 1994: 7: 188-200.
16. Malmstrom J, Christophersen C, Barrero A F, Oltra J E, Justicia J, Rosales A. Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor. J Nat Prod 2002: 65: 364-367.
17. Mitscher L A, Clark I, G W, Bokelman G H. Method for the preparation of prostaglandin intermediates from a mold metabolite. US Patent 1978: 4103091.
18. Pebay A, Toutant M, Premont J et.al. Sphingosine-1-phosphate induces proliferation of astrocytes: Regulation by intracellular signalling cascades. Eur J Neurosci 2001: 13: 2067-2076.
19. Kiely P A, Sant A, O'Connor R. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 2002: 277: 22581-22589.
20. Davis R J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993: 268: 14553-14556.
21. Kim A L, Zhu Y, Zhu H et.al. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol 2006: 15: 538-546.
22. Prietzsch H, Brock J, Kleine H D, Liebe S, Jaster R. Interferon-alpha inhibits cell cycle progression by Ba/F3 cells through the antagonisation of interleukin-3 effects on key regulators of G(1)/S transition. Cell Signal 2002: 14: 751-759.
23. Palmer A, Gavin A C, Nebreda A R. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: P90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. EMBO J 1998: 17: 5037-5047.
24. Walsh S, Margolis S S, Kornbluth S. Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol Cancer Res 2003: 1: 280-289.